Alert: Rating Downgrade (1/5/24)-Neurocrine Biosciences Inc (NASDAQ: NBIX).
Stock Rating Downgrade In the last week the Value Trend Rating for Neurocrine Biosciences Inc (NASDAQ: NBIX) weakened from B to C reflecting eroding fundamentals and low Appreciation Potential. Recent Price Action On 1/5/24, Neurocrine […]